Surfactants for heterogeneous processes in liquid or supercritical CO.sub.2

Heterogeneous polymer mixtures comprising a polymer in liquid or supercritical CO.sub.2 are stabilized by employing a poly(propylene oxide) or poly(butylene oxide) based surfactant. These surfactants are especially well suited for stabilizing heterogeneous polymer mixtures formed by micronizing techniques as well as by precipitation of a compressed fluid antisolvent applications.Board of Regents, University of Texas Syste

Energy-efficient polymeric gas separation membranes for a sustainable future: A review

AbstractOver the past three decades, polymeric gas separation membranes have become widely used for a variety of industrial gas separations applications. This review presents the fundamental scientific principles underpinning the operation of polymers for gas separations, including the solution-diffusion model and various structure/property relations, describes membrane fabrication technology, describes polymers believed to be used commercially for gas separations, and discusses some challenges associated with membrane materials development. A description of new classes of polymers being considered for gas separations, largely to overcome existing challenges or access applications that are not yet practiced commercially, is also provided. Some classes of polymers discussed in this review that have been the focus of much recent work include thermally rearranged (TR) polymers, polymers of intrinsic microporosity (PIMs), room-temperature ionic liquids (RTILs), perfluoropolymers, and high-performance polyimides

Trapping virtual pores by crystal retro-engineering

Stable guest-free porous molecular crystals are uncommon. By contrast, organic molecular crystals with guest-occupied cavities are frequently observed, but these cavities tend to be unstable and collapse on removal of the guests—this feature has been referred to as ‘virtual porosity’. Here, we show how we have trapped the virtual porosity in an unstable low-density organic molecular crystal by introducing a second molecule that matches the size and shape of the unstable voids. We call this strategy ‘retro-engineering’ because it parallels organic retrosynthetic analysis, and it allows the metastable two-dimensional hexagonal pore structure in an organic solvate to be trapped in a binary cocrystal. Unlike the crystal with virtual porosity, the cocrystal material remains single crystalline and porous after removal of guests by heating

Influence of Diffusivity and Sorption on Helium and Hydrogen Separations in Hydrocarbon, Silicon, and Fluorocarbon-Based Polymers

The permeability–selectivity upper bounds show that perfluoropolymers have uniquely different separation characteristics than hydrocarbon-based polymers. For separating helium from hydrogen, these differences are particularly dramatic. At a given helium permeability, the upper bound defined by perfluoropolymers has helium/hydrogen selectivities that are 2.5 times higher than that of the upper bound defined by hydrocarbon-based polymers. Robeson hypothesized that these differences in transport properties resulted from the unusual sorption relationships of gases in perfluoropolymers compared to hydrocarbon-based polymers, and this paper seeks to test this hypothesis experimentally. To do so, the gas permeability, sorption, and diffusion coefficients were determined at 35 °C for hydrogen and helium in a series of hydrocarbon-, silicon-, and fluorocarbon-based polymers. Highly or completely fluorinated polymers have separation characteristics above the upper-bound for helium/hydrogen separation because they maintain good diffusivity selectivities for helium over hydrogen and they have helium/hydrogen sorption selectivities much closer to unity than those of hydrocarbon-based samples. The silicon-based polymer had intermediate sorption selectivities between those of hydrocarbon-based polymers and perfluoropolymers. Comparisons of hydrogen and helium sorption data in the literature more broadly extend the conclusion that helium/hydrogen sorption selectivity is rather different in hydrocarbon and fluorocarbon-based media

Ezetimibe added to statin therapy after acute coronary syndromes

BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known. METHODS: We conducted a double-blind, randomized trial involving 18,144 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and had LDL cholesterol levels of 50 to 100 mg per deciliter (1.3 to 2.6 mmol per liter) if they were receiving lipid-lowering therapy or 50 to 125 mg per deciliter (1.3 to 3.2 mmol per liter) if they were not receiving lipid-lowering therapy. The combination of simvastatin (40 mg) and ezetimibe (10 mg) (simvastatin-ezetimibe) was compared with simvastatin (40 mg) and placebo (simvastatin monotherapy). The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, unstable angina requiring rehospitalization, coronary revascularization ( 6530 days after randomization), or nonfatal stroke. The median follow-up was 6 years. RESULTS: The median time-weighted average LDL cholesterol level during the study was 53.7 mg per deciliter (1.4 mmol per liter) in the simvastatin-ezetimibe group, as compared with 69.5 mg per deciliter (1.8 mmol per liter) in the simvastatin-monotherapy group (P<0.001). The Kaplan-Meier event rate for the primary end point at 7 years was 32.7% in the simvastatin-ezetimibe group, as compared with 34.7% in the simvastatin-monotherapy group (absolute risk difference, 2.0 percentage points; hazard ratio, 0.936; 95% confidence interval, 0.89 to 0.99; P = 0.016). Rates of pre-specified muscle, gallbladder, and hepatic adverse effects and cancer were similar in the two groups. CONCLUSIONS: When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit